Taste test for Parkinson's and Lewy body disease
Part of Brain & nervous system, Mental health clinical trials.
This study measures how well people with Parkinson's or Lewy body disease can taste, using a special test. It aims to understand if taste problems are linked to these conditions and could help with earlier diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 or older) and have given your written consent to join.
- Your body mass index (BMI) must be under 30 (you can ask your doctor to check).
- You must not have diabetes (type 1 or type 2).
- You must not be a heavy smoker (more than 4 cigarettes per day).
- You must not have had COVID-19 in the last 6 months.
- You must not be taking any medication that affects your sense of taste.
- You need a normal thinking and memory test score (if you are a healthy volunteer) or meet specific Parkinson's or Lewy body disease criteria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how frontotemporal dementia affects your sense of taste by measuring the brain's response to different tastes. Participants will undergo a taste test while their brain activity is recorded.
This study tracks how taste perception works in people with different stages of memory and thinking problems, including mild to moderate Alzheimer-type conditions. It uses non-painful taste testing and brain-wave measurements to understand changes over time and may help improve how these conditions are assessed.
This study checks if people with vision loss have changes in taste and smell. You will take taste and smell tests while brain activity is recorded with small sensors on your head.
This study looks at how sense of smell and taste affect the nutritional health of people with ALS. If you have early-stage ALS and want to help doctors learn how to support better eating, this may be for you.
This study measures blood biomarkers (measurable substances in blood) in people with Parkinson’s at different stages. It may help doctors understand how Parkinson’s changes over time and could guide future testing or treatments.
This trial is testing a special PET scan that uses a radioactive tracer (18F-mFBG) to see how much it is taken up by the heart. The goal is to help tell Lewy body disease (Parkinson's or Lewy body dementia) apart from other brain disorders.
Hear when a new Idiopathic Parkinson's Disease and Lewy Body Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.